Baird Maintains Outperform on Laboratory Corp, Lowers Price Target to $237
Portfolio Pulse from Benzinga Newsdesk
Baird analyst Eric Coldwell maintains an Outperform rating on Laboratory Corp (NYSE:LH) but lowers the price target from $251 to $237.
September 18, 2023 | 5:55 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Baird analyst maintains Outperform rating on Laboratory Corp but lowers the price target from $251 to $237.
The news is directly about Laboratory Corp (LH). While the Outperform rating is maintained, the lowering of the price target might indicate a slightly less optimistic outlook for the company's stock in the short term. However, the overall impact is neutral as the Outperform rating suggests that the analyst still expects the stock to do better than the market average.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100